Power of computed-tomography-defined sarcopenia for prediction of morbidity after pancreaticoduodenectomy

BMC Medical Imaging

Table 1 Baseline characteristics

	Complication < IIIb	Complication IIIb ≤	p<	No Grade B or C fistula	Grade B or C fistula	p<
Patient data
Gender (female / male)	39 / 63	16 / 21	0.60	42 / 71	13 / 13	0.23
Age (years)	60.6	65.6	0.18	60.9	62.0	0.81
BMI (kg/m²)	24.9	26.2	0.03	24.8	26.9	0.05
Comorbidities
cardiovascular	55	29	0.01	63	21	0.21
cerebrovascular	4	2	0.71	5	1	0.89
pulmonary	14	12	0.01	16	10	0.01
endocrine	49	18	0.99	54	13	0.87
gastrointestinal	61	21	0.70	66	16	0.80
hemato−/oncologic	7	2	0.75	8	1	0.54
Immunologic	4	2	0.71	4	2	0.36
gynecologic	12	6	0.50	15	3	0.80
urologic	15	6	0.84	16	5	0.53
chronic pancreatits	34	9	0.30	37	6	0.33
metabolic syndrome	2	3	0.09	4	1	0.95
arterial hypertension	48	27	0.01	54	21	0.01
obesity	11	10	0.20	14	7	0.06
new diabetes mellitus	7	1	0.35	8	0	0.16
impaired physical performance	18	7	0.83	22	3	0.37
loss of appetite	18	9	0.35	20	7	0.25
feeling of abdominal pressure	40	10	0.21	40	10	0.69
ascites	2	0	0.40	2	0	0.50
jaundice	48	17	0.98	54	11	0.70
peripheral edema	2	0	0.40	2	0	0.50
fever	7	3	0.78	7	3	0.32
night sweats	6	1	0.44	6	1	0.75

Continuous parameters are reported as median, and categorical parameters are counted. p: level of significance was determined by the Mann-Whitney-U Test. bold numbers indicate p < 0.05

ISSN: 1471-2342